News for Evoke Pharma, Inc. (EVOK)

The following slide deck was published by Evoke Pharma, Inc.

On March 24, 2025, Bleichroeder LP (Trades, Portfolio) executed a substantial reduction in its holdings of Evoke Pharma Inc (EVOK). The firm decreased its posit

Significant Transaction by Bleichroeder LP (Trades, Portfolio) On March 19, 2025, Bleichroeder LP (Trades, Portfolio) executed a notable stock transaction invol

Total Revenue: $10.2 million for the year ending December 30, 2024, compared to $5.2 million for 2023.Fourth Quarter Revenue: $3.3 million, up from $1.7 millio

Mar 13, 2025 / 08:30PM GMTOperator Good afternoon and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instruct

Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-year Strong growth in key commercial metrics, including prescribe

**media[566097]**

**media[548579]**

Cumberland Pharmaceuticals (CPIX) experienced a significant stock movement, with its share price dropping by 5.02% to $2.46. The trading volume reached 12,902 s

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at where Evoke Pharma, Inc.

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends

SOLANA BEACH, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. ( EVOK), a specialty pharmaceutical company focused primarily on treatments for gas

Regencell Bioscience Holdings (RGC) experienced a significant stock drop of 5.46%. The stock price fell to $6.54 with a trading volume of 32,386 shares and a tu

Canopy Growth Corporation (CGC) saw its stock price rise significantly by 5.20%. The stock is currently priced at $4.64 per share, with a trading volume of 4.30

Ironwood Pharmaceuticals (IRWD) experienced a notable stock surge with shares rising by 5.01%. The stock was last reported at $4.40 per share with a trading vol

Maryland-based GlycoMimetics, Inc. (GLYC), a biotechnology company is up over 163 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of V.F. Corporation VFC rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results. VF ...

Evoke Pharma holds Buy rating with $18 target from Laidlaw

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.77% to 42,440.12 whil...